№ lp_2_3_18460
File format: docx
Character count: 56960
File size: 3291 KB
Detailed reference guide for medical practitioners describing facial anatomy, subcutaneous structures, and muscle groups relevant for advanced dermal filler procedures.
Year:
2026
Type:
Educational publication
Topic:
Dermatology / Aesthetic Medicine
Author:
All rights reserved
Target audience:
Medical professionals and aesthetic practitioners
Content focus:
Facial anatomy, subcutaneous tissue, muscles, and advanced dermal filler techniques
Regions covered:
Periorificial craniofacial region, cervicofacial region, periorbital, nasal, and perioral areas
Structure focus:
Musculoaponeurotic system, SMAS, subcutaneous fat layers, facial muscles
Format:
Written and produced manual
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Organization:
STATDDS
Associated Organizations:
Merz; Allergan; Henry Schein; AAFE; BD
Products Mentioned:
Xeomin; Belotero Balance; Radiesse; Botox; Juvederm; Voluma; Comfortox Syringes; Bacteriostatic 0.9% Sodium Chloride; Alcohol Prep Pads
Document Type:
Product and Ordering Information Sheet
Industry:
Medical and Dental Aesthetics
Intended Audience:
Dental Professionals; Medical Professionals; Clinicians
Distribution Information:
Exclusive dental distribution of specified products by STATDDS
Contact Information:
800-693-9076; [email protected]
Note:
; 866-862-1211; 800-347-4500
Website:
STATDDS.com
Supplies Covered:
Syringes for reconstitution and injection; starter kits; bacteriostatic saline; ice packs; sterile needles
Packaging Details:
Individual sterile packaging; box quantities; vial quantities
Order References:
Henry Schein Order #890-8538; #104-6851; #987-8204; #987-1329
Year:
2019
Region / City:
N/A
Topic:
Dermal Toxicology, Officer Roles, Society of Toxicology
Document Type:
Roles and Responsibilities
Organization / Institution:
Society of Toxicology
Author:
N/A
Target Audience:
DTSS Officers, Society of Toxicology Members
Period of Validity:
Ongoing
Approval Date:
N/A
Date of Changes:
N/A
Document Type:
Medical instruction sheet
Subject:
Pre-procedure guidelines for dermal filler injections
Medications to Avoid:
Aspirin, aspirin-containing cold medications, Ibuprofen, Naprosyn, Vitamin E, Fish Oil, Omega 3 and Omega 6 supplements, Gingko Biloba, Turmeric
Arrival Requirement:
30–45 minutes prior to appointment
Special Instructions:
Discontinue listed medications 7–10 days before appointment
Product Mentioned:
Voluma
Post-Procedure Restrictions:
Avoid dental work and immunizations for 3 weeks after Voluma injections
Antiviral Prophylaxis:
Valtrex 2 grams twice daily for patients with history of cold sores
Additional Requirement for First-Time Patients:
Bring an old facial photograph
Intended Audience:
Patients scheduled for dermal filler injections
Organization:
STATDDS
Associated Organizations:
Merz; Allergan; Henry Schein; AAFE; BD
Products Mentioned:
Xeomin; Belotero Balance; Radiesse; Botox; Juvederm; Voluma; Comfortox Syringes; Bacteriostatic 0.9% Sodium Chloride; Alcohol Prep Pads
Document Type:
Product and Ordering Information Sheet
Industry:
Medical and Dental Aesthetics
Intended Audience:
Dental Professionals; Medical Professionals; Clinicians
Distribution Information:
Exclusive dental distribution of specified products by STATDDS
Contact Information:
800-693-9076; [email protected]
Note:
; 866-862-1211; 800-347-4500
Website:
STATDDS.com
Supplies Covered:
Syringes for reconstitution and injection; starter kits; bacteriostatic saline; ice packs; sterile needles
Packaging Details:
Individual sterile packaging; box quantities; vial quantities
Order References:
Henry Schein Order #890-8538; #104-6851; #987-8204; #987-1329
Year:
2002
Product name:
Abine (Abamectina 1.8% p/v)
Active substance:
Abamectin
Study type:
Acute oral toxicity study; Acute dermal toxicity study
Test guidelines:
OECD No. 423; OECD No. 402
GLP compliance:
Yes
Laboratory:
Jai Research Foundation
Location:
Valvada 396 108; Gujarat; India
Author:
Aldrin Joseph, S.
Document numbers:
JRF 3719; JFR 3720
Test species:
Rat (Wistar)
Sex:
Male and female
Route of administration:
Oral (gavage); Dermal (semi-occlusive, 24 h)
Dose levels:
200, 500, 2000 mg/kg bw (oral); 2000 mg/kg bw (dermal)
Oral LD50:
500–2000 mg/kg bw
Dermal LD50:
> 2000 mg/kg bw
Observation period:
14 days
Regulatory references:
Directive 2001/59/EC; Regulation (EC) 1272/2008; Council Directive 67/548/EC
Hazard classification:
R22 (Harmful if swallowed); H302 (Harmful if swallowed); H318 (Causes serious eye damage)
Institution:
Baylor College of Medicine
Department:
Otolaryngology – Head & Neck Surgery
Document type:
Course overview document
Revision date:
April 16, 2021
Academic level:
Medical students
Rotation type:
Selective rotation
Rotation duration:
Two weeks
Clinical sites:
Ben Taub General Hospital; Michael E. DeBakey Veterans Affairs Medical Center; Texas Children’s Hospital
Geographic location:
Texas Medical Center, Houston, Texas
Course prerequisites:
None
Course directors:
Sunthosh Sivam, MD
Course coordinator:
Evelyn Trevino
Educational framework:
BCM Core Competencies and Graduation Goals
Assessment methods:
Case log; evaluations; E*value student performance assessment
Related policies:
Baylor College of Medicine Teacher-Learner Compact
Year:
Not specified
Region / City:
Not specified
Theme:
Radiology, CT scans
Document Type:
Medical report
Organization / Institution:
Not specified
Author:
Dr. Vilayat Ali, Dr. Sandeep Agarwal, Dr. Annie Agarwal, Dr. Shivani Agarwal
Target Audience:
Healthcare professionals, Radiologists
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2024
Region / City:
USA
Topic:
Ice Hockey Safety Regulations
Document Type:
Guidelines
Organization:
USA Hockey
Author:
USA Hockey
Target Audience:
Officials and Coaches
Effective Period:
2024-25 Season
Approval Date:
08/01/2024
Note:
Year
Theme:
Medical Referral
Document Type:
Referral Form
Institution:
Bristol Dental Hospital
Target Audience:
Healthcare professionals
Note:
Year
Document Type:
Written Consent for Research Study
Institution / Organization:
HCMC
Author:
Dr. Uzma Samadani, Dr. Thomas Bergman
Target Audience:
Student Athletes
Year:
2024
Region / City:
Morriston Hospital, Swansea Bay University Health Board
Topic:
Hip Fracture, Frailty, Orthogeriatrics
Document Type:
Report
Organization / Institution:
Swansea Bay University Health Board
Author:
Rhodri Davies, Charlotte Le Brocq
Target Audience:
Healthcare Professionals, Hospital Management, Medical Team
Action Required:
Approval
Approval Date:
23 April 2024
Period of Action:
2024
Date of Last Update:
February 2024
Year:
2013
Region / city:
N/A
Theme:
Oral cancer surgery
Document type:
Study
Institution:
N/A
Author:
N/A
Target audience:
Medical professionals, researchers
Period of action:
2011-2013
Date of approval:
N/A
Date of amendments:
N/A
Year:
2026
Region / City:
Germany
Subject:
Oncology, Head and Neck Cancer
Document Type:
Certification Catalogue / Standards
Issuing Organization:
Certification Committee for Head and Neck Cancers
Chairmen:
Univ.-Prof. Dr. med. Dr. med. dent. M. Heiland, Prof. Dr. H. Iro
Working Groups Involved:
ACO, ADT, ADO, AHMO, AIO, AOP, OPH, AGORS, APM, PRIO, PSO, ARO, ASO, BDP, BVK, BVDST, CAO, BVHNO, DBL, DGPRÄC, DGHNO, DGHO, DeGIR, DGMKG, DGNR, DGN, DGP, DGPP, DEGRO, DGZMK, DÖSAK, DRG, DVSG, IAG-KHT, KOK
Guidelines Referenced:
S3 Laryngeal Cancer, S3 Oral Cavity Cancer, S3 Oropharynx/Hypopharynx
Applicable Classifications:
TNM 8th edition 2017, ICD-10-GM 2025, ICD-O-3 2019, OPS 2025
Audit Version:
H2
Date of Document:
11.12.2025
Changes Implemented:
2024, effective from 01.01.2025
Scope:
Technical and medical requirements for diagnostics, treatment, and certification of head and neck cancer centres
Network / Main Cooperation Partners:
Listed in OnkoZert Master Data Sheet
Clinical Sites:
Multiple, with specified distance limitations
Patient Involvement:
Annual events for patients and referrers
Target Audience:
Oncology centres undergoing certification and audits
Data Sheets / Annexes:
Excel templates for centre information and cooperation agreements
Procedure Code:
CPT 51715
Procedure Name:
Endoscopic injection of implant material into the submucosal tissues of the urethra and/or bladder neck
Clinical Indication:
Stress urinary incontinence in women
Population:
Women with stress urinary incontinence
Evidence Sources:
Cochrane Review (Kirchin 2012); NICE 2005; NICE 2019; American Urology Association 2017; Syan 2016; MODA 2019; Aetna 2019
Study Types Referenced:
Randomized controlled trials; case series; systematic review; guideline statements
Comparators:
Conservative treatment; placebo injection; surgical management; pelvic floor muscle training
Reported Outcomes:
Continence rates; quality of life; patient satisfaction; adverse events; objective cure
Adverse Events Reported:
Urinary tract infection; urinary retention; dysuria; abscess; urgency of micturition; prolonged pain; haemorrhage; migration of bulking agent; allergic reaction
Regulatory Reference:
FDA-cleared bulking agents listed (Coaptite, Contigen, Durasphere, Macroplastique, Uryx)
Coverage Criteria:
Prior conservative management; defined duration of symptoms; documented improvement after initial treatments; limitation on number of injections
Guideline Recommendations:
Consider in patients unsuitable for or declining surgery; counseling on limited long-term efficacy and potential need for repeat injections
Review Date Mentioned:
August 2019
Last updated:
12 October 2023
Effective date:
1 November 2023 (subject to the passage of legislation)
Country:
Australia
Sector:
Health
Subject:
Otolaryngology, Head and Neck Surgery and Diagnostic Audiology Services
Type of document:
Government policy update
Issuing body:
Department of Health and Aged Care
Related framework:
Medicare Benefits Schedule (MBS)
Related legislation:
Health Insurance Act 1973
Consultative bodies:
MBS Review Taskforce; Otolaryngology, Head and Neck Surgery Clinical Committee; Otolaryngology, Head and Neck Surgery Implementation Liaison Group
Target audience:
Health providers; Medical specialists; Audiology professionals
Implementation and compliance:
Subject to MBS compliance processes, audits, and post-implementation review
Scope:
Amendments to specified MBS item descriptors and billing conditions
Year:
2022
Region / City:
N/A
Topic:
Oncology, Pathology
Document Type:
Protocol
Organization:
CAP (College of American Pathologists)
Authors:
Raja R. Seethala, MD; Wonwoo Shon, DO; Bonnie L. Balzer, MD, PhD; Umamaheswar Duvvuri, MD, PhD; Nima M. Gharavi, MD, PhD; William Lydiatt, MD
Intended Audience:
Pathologists, Clinical Laboratories, Medical Institutions
Effective Period:
From March 2023
Approval Date:
September 2022
Amendment Date:
N/A
Organization:
Society for Immunotherapy of Cancer
Document Type:
Bibliography
Subject:
Cancer Immunotherapy
Focus:
Head and Neck Squamous Cell Carcinoma
Publication Date:
December 17, 2018
Date Range of Literature Search:
December 1, 2013 – December 17, 2018
Search Limits:
Humans, Clinical Trial, Meta-Analysis, Practice Guideline, Randomized Controlled Trial, Review
Therapeutic Agents Covered:
Pembrolizumab, Nivolumab, Cemiplimab, Durvalumab
Biomarkers and Targets:
PD-1, PD-L1, HPV
Total References Identified:
199
Total Duplicates Removed:
42
Total Records in Bibliography:
157
Topics Included:
Immune checkpoint inhibitors, biomarkers, combination immunotherapy, adverse events, toxicity, vaccine, adjuvant and neoadjuvant immunotherapy, rare head and neck cancers
Year:
2014
Region / City:
Bristol, United Kingdom
Subject:
Head and neck suspected cancer
Document Type:
Medical referral form
Institution:
Bristol Dental Hospital
Author:
Bristol Dental Hospital Administration
Target Audience:
Healthcare professionals referring patients
Submission Methods:
Choose & Book system or fax
Patient Information Included:
Yes
Medical History Included:
Yes
Consent Required:
Yes
Special Requirements Section:
Yes
Year:
2025
Region / City:
Nigeria
Topic:
Cardiometabolic risk and anthropometric measures
Document Type:
Original research article
Institution:
Tertiary health facility, Nigeria
Author:
Not specified
Study Population:
Adults with Type 2 diabetes mellitus and healthy controls
Sample Size:
180 (120 T2DM patients, 60 controls)
Methodology:
Comparative cross-sectional study
Measurements:
Neck circumference, waist circumference, waist-hip ratio, body mass index, HOMA-IR
Exclusion Criteria:
Pregnant women, thyroid disease, goiter, prior neck surgery
Study Duration:
6 months
Year:
2014
Region / City:
Bristol, UK
Subject:
Head and Neck Cancer Referrals
Document Type:
Medical Referral Form
Issuing Institution:
Bristol Dental Hospital
Target Audience:
Healthcare Professionals
Submission Method:
Choose & Book or Fax
Patient Consent Required:
Yes
Special Care Information Included:
Yes
Contact Details Provided:
Yes